Samfine Creation Obtains Publication Printing Permit in China
Samfine Creation obtained a Publication Printing Business Permit from the relevant PRC press and publication authorities, authorizing it to conduct domestic publication printing operations within the PRC. The Company believes this permit represents a milestone in its efforts to expand beyond its existing international focused order base into the PRC's domestic publication printing market. Leveraging its printing expertise and technical capabilities, Samfine Printing plans to explore opportunities in the domestic IP-based and educational publication segments. Previously, regulatory restrictions applicable to foreign invested enterprises limited Samfine's participation in certain PRC domestic publication printing activities and the Company's publication printing business was primarily focused on overseas orders. While this contributed to the Company's world-class manufacturing capabilities, the Company was limited to participate in certain PRC domestic publication printing operations. This permit is expected to address regulatory constraints and expand the scope of business activities that the Company may undertake in the PRC, subject to applicable laws and regulations.
Trade with 70% Backtested Accuracy
Analyst Views on SFHG
About SFHG
About the author


Nasdaq Compliance Notification: Samfine Creation Holdings Group Limited has been notified by Nasdaq that it no longer meets the minimum bid price requirement of $1 per share, with a compliance period until September 22, 2025, to regain compliance.
Future Actions and Risks: The Company is evaluating options to regain compliance but cannot guarantee success, as future results may differ from expectations due to various risks and uncertainties.

Financial Performance: Samfine Creation Holdings Group Limited reported a revenue increase of 61.3% to HK$81.9 million (US$10.5 million) for the six months ending June 30, 2024, alongside a net income of HK$0.8 million (US$106,105), reversing a net loss from the previous year.
Operational Insights: The growth in revenue was attributed to higher demand for book products and novelty packaging, while increases in general administrative and selling expenses were noted due to rising legal fees and transportation costs.

DBV Technologies Stock Surge: DBV Technologies S.A. shares rose 36.9% in pre-market trading after announcing alignment with the FDA for an accelerated approval pathway for the Viaskin peanut patch in toddlers aged one to three years.
Market Movements: Various stocks experienced significant changes in pre-market trading, with Palisade Bio, Inc. gaining 125%, while Avinger, Inc. saw a decline of 50%.





